Jefferies Reiterated Buy on China Biologic Products (CBPO) Following Announced Xinjiang Deyuan Collaboration
Tweet Send to a Friend
Jefferies reiterated a Buy rating and $146.00 price target on China Biologic Products (NASDAQ: CBPO) Following the announced strategic collaboration ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
